Improved selectivity of a high-performance liquid chromatography assay for debrisoquine and its 4-hydroxy metabolite from urine

Kjel A. Johnson, Vasanti Kolatkar, Robert J. Straka

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

Debrisoquine is an antihypertensive drug that displays polymorphic metabolism and has been used to determine hydroxylator status in human subjects. A high-performance liquid chromatographic method for the simultaneous urine analysis of debrisoquine (D) and its primary metabolite, 4-hydroxydebrisoquine (4-OHD), is described. A cyanopropyl (CN) extraction column and CN analytical column were used with a mobile phase consisting of 20% acetonitrile/20 mM sodium dihydrogen orthophosphate (pH = 7.1) at a flow rate of 1.5 ml/min. The peaks of interest, as well as the internal standard, were eluted from the column in less than 14 min. The method described was validated for within-day and between-day accuracy and precision for both D and 4-OHD. Coefficients of variation at all concentrations tested were <4.1% for D and <9.3% for 4-OHD. The assay was used to evaluate D/4-OHD ratios, thereby determining hydroxylation status in 65 healthy male volunteers.

Original languageEnglish (US)
Pages (from-to)478-480
Number of pages3
JournalTherapeutic drug monitoring
Volume12
Issue number5
DOIs
StatePublished - Sep 1990

Keywords

  • 4-Hydroxydebrisoquine
  • Debrisoquine
  • High-performance liquid chromatography
  • Metabolism
  • Polymorphic

Fingerprint Dive into the research topics of 'Improved selectivity of a high-performance liquid chromatography assay for debrisoquine and its 4-hydroxy metabolite from urine'. Together they form a unique fingerprint.

Cite this